2025

1. Adherence to periprocedural antithrombotic treatment recommendations and its prognostic impact in patients with high ischemic and hemorrhagic risk

   Revista Espanola de Cardiologia, Vol. 78, Núm. 5, pp. 416-424

2. Age-related penetrance of phospholamban p.Arg14del cardiomyopathy

   European Journal of Heart Failure

3. Analysis of key proinflammatory mechanisms in cardiovascular pathology through stimulation with lipopolysaccharide and urban particulate matter in mouse atrial cardiomyocytes

   Environmental Toxicology and Pharmacology, Vol. 114

4. Artificial intelligence: a promising tool for the clinical cardiologist

   Expert Review of Cardiovascular Therapy

5. Assessment of satisfaction level with an electronic referral system between Primary Care and Cardiology

   Atencion Primaria, Vol. 57, Núm. 4

6. Cardiac electrical abnormalities in a mouse model of left ventricular non-compaction cardiomyopathy

   PLoS ONE, Vol. 20, Núm. 5 May

7. Cost-effectiveness of apixaban in non-valvular atrial fibrillation (NVAF) based on effectiveness data from a Spanish study in clinical practice (real-world evidence)

   Expert review of cardiovascular therapy, Vol. 23, Núm. 1-2, pp. 45-51

8. Effects of anti-inflammatory therapy in acute heart failure: a systematic review and meta-analysis

   Heart Failure Reviews, Vol. 30, Núm. 3, pp. 575-587

9. Effects of routine invasive management on reinfarction risk in older adults with frailty and non-ST-segment elevation myocardial infarction: a subanalysis of a randomised clinical trial

   Heart

10. Final 5-year outcomes of the Epic02 – RANGO study: A real-world registry of the durable fluoroacrylate polymer-based sirolimus-eluting Angiolite® stent

    Cardiovascular Revascularization Medicine

11. Geriatric conditions and invasive management in frail patients with NSTEMI. A subgroup analysis of a randomized clinical trial

    Revista Espanola de Cardiologia, Vol. 78, Núm. 4, pp. 319-326

12. Hypertrophic cardiomyopathy and atrial fibrillation: The Cardiomyopathy/Myocarditis Registry of the EURObservational Research Programme of the European Society of Cardiology

    Open Heart, Vol. 12, Núm. 1

13. Impact of gender on in-hospital and long-term outcomes after transcatheter aortic valve implantation: an analysis of the Spanish TAVI registry

    Revista Espanola de Cardiologia, Vol. 78, Núm. 4, pp. 338-346

14. Impact of lesion hemodynamic pattern and calcium morphology on the functional efficacy of coronary intravascular lithotripsy

    Cardiovascular Revascularization Medicine

15. Intravenous acetazolamide in patients with acute heart failure and persistent volume overload

    Revista Espanola de Cardiologia, Vol. 78, Núm. 8, pp. 736-738

16. Left ventricular ejection fraction decline and cardiovascular events in suspected cardiomyopathy with excessive trabeculation: toward precision medicine

    Revista Espanola de Cardiologia

17. Microbial Insights: The Role of Diet in Modulating Gut Microbiota and Metabolites After Acute Coronary Syndrome

    Molecular Nutrition and Food Research

18. NT-proBNP to guide risk stratification after cardiac rehabilitation in patients with ST-segment elevation myocardial infarction

    European Journal of Internal Medicine, Vol. 137, pp. 83-89

19. Naxos Disease and Related Cardio-Cutaneous Syndromes

    JACC: Advances, Vol. 4, Núm. 2

20. Nuevo balón scoring para el tratamiento de lesiones coronarias con calcificación de moderada a grave. Primer estudio en humanos Naviscore

    REC: Interventional Cardiology, Vol. 7, Núm. 2, pp. 91-98